Corporate finance team advises Calleva on Swedish merger

The corporate finance team at Westcotts Corporate has advised Calleva, based in Somerset, on its merger with Wellma, a Swedish nutraceuticals and pharmaceuticals group.

Calleva is a UK-based specialist in the development and manufacturing of nutraceutical ingredients and products in the forms of nutritional liquids and powder. Based in Bridgwater, Calleva is recognised for its high quality, innovative formulations and customer care. Its products have a wide range of applications in sports nutrition, health and lifestyle.

This strategic move marks Wellma’s entry into a new European market, the United Kingdom, complementing its broad European presence. Calleva brings unique capabilities in formulations, sourcing, excellent taste profiles and high-quality manufacturing standards matching Wellma’s commitment to high quality, niche capabilities, and innovation.

Will Mudd, corporate finance director at Westcotts helped lead the M&A advisory team for Calleva.

He said: “It is not often that a deal evolves which so perfectly aligns the interests of all parties. The Calleva team are very high calibre and will be a huge asset to Wellma and the wider European group. The exciting growth and expansion plans are another great example of why the South West is a great place to do business.”